Odyssey Therapeutics, Inc. Share Price

Odyssey Therapeutics, Inc. Share Price

NASDAQ: ODTX
$19.21
+$0.39 (2.10%) Last updated on 07 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Odyssey Therapeutics, Inc. Stock Performance

Open
$18.45
Prev. Close
$18.82
Circuit Range
N/A
Day Range
$18.45 - $19.57
Year Range
$15.45 - $28.96
Volume
25,780
Average Traded
$19.23

Odyssey Therapeutics, Inc. Share Price Today

As of 8 November 2026, Odyssey Therapeutics, Inc.'s share price is $19.21. The stock opened at $18.45, compared to its previous close of $18.82. During today's trading session, Odyssey Therapeutics, Inc.'s share price traded between $18.45 and $19.57, with an average price of $19.01. Over the past 52 weeks, the stock has recorded a high of $28.96 and a low of $15.45. In terms of performance, Odyssey Therapeutics, Inc.'s share price has risen by 13.10% over the last six months and is up 13.10% on a year-on-year basis.

Odyssey Therapeutics, Inc. Share Price Chart

Line chart of the Odyssey Therapeutics, Inc. price trend over the selected period. The price rose overall, ranging from 18.45 to 19.69, ending at 19.21.
$18.45$19.57
L
Show Current Price
H

Odyssey Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.00
Revenue (TTM)
N/A
Return On Equity (TTM)
-38.35%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
N/A

Odyssey Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2026Sep 2026
Revenue$0.00$0.00
Net Profit-$52.79-$53.06
Net Profit MarginN/AN/A
Income ChangeN/A-0.51%

About Odyssey Therapeutics, Inc.

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Odyssey Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$19.66
$19.18
-2.17%
Oct 2026
$22.00
$19.61
-11.85%
Sep 2026
$24.44
$22.24
-14.16%
Aug 2026
$19.00
$25.91
+37.45%
Jul 2026
$18.57
$18.85
+0.94%
Jun 2026
$17.94
$18.68
+9.92%
May 2026
$20.11
$16.99
N/A

ODTX Share Price FAQs